Perspectives for immune plasma treatment of COVID-19

Başak Sayinalp Olgu Erkin Çinar İbrahim Celallettin Haznedaroğlu

Published in: Turkish journal of medical sciences (2021)

Even though mechanisms of action of plasma therapy are not fully delineated, it was shown that it could lead to a reduction in mortality since other alternatives such as monoclonal antibodies or SARS-CoV-2 hyperimmunoglobulin require much more time and effort to be developed.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
risk factors
stem cells
cardiovascular disease
combination therapy
replacement therapy
cell therapy